||Mohamad E. Allaf, MD
|Dr. Allaf is an Assistant Professor of Urology and Biomedical Engineering at the Brady Urological Institute and Director of Minimally Invasive and Robotic Surgery at the Johns Hopkins Hospital. He joined the staff after receiving his undergraduate and medical degrees from the Johns Hopkins University and completing his residency and advanced training in Urology at Johns Hopkins as well.
His main clinical interest includes the treatment of kidney tumors and prostate cancer in the least morbid way possible. He specializes in the management of kidney tumors via laparoscopic (total and partial kidney removal) and percutaneous (non-surgical) approaches. He also has an interest in the careful and active observation of select small kidney tumors. His other areas of focus include performing nerve sparing radical prostatectomy in all its forms (open, laparoscopic, and robotic) as well as reconstructive laparoscopy (pyeloplasty) and laparoscopic management of testicular cancer (retroperitoneal lymph node dissection).
His research endeavors involve investigating approaches to minimize the morbidity of urologic surgery and the development of ways to decrease injury to the neurovascular bundles and hasten erection recovery following radical prostatectomy. Dr. Allaf has been the recipient of numerous academic awards, including placing first in the 2005 American Urological Association clinical and laboratory research annual essay contests. He has written and published numerous research articles, textbook chapters, patents and video presentations in the field of Laparoscopic and Robotic Urologic Surgery.
||Trinity J. Bivalacqua, M.D, Ph.D
|Trinity J. Bivalacqua, M.D., Ph.D., Assistant Professor of Urology and Oncology, was born in New Orleans, Louisiana and graduated from Tulane University with undergraduate, graduate and medical degrees. He joined the faculty after completing his General Surgery and Urology training at Johns Hopkins Hospital. He also received an American Urological Association (AUA) Foundation Fellowship for his pioneering work on neuroregulatory control of penile erection.
Dr. Bivalacqua has an active clinical practice in Urologic Oncology, Andrology and Benign Prostatic disease. His specific interest is in Prostate, Bladder and Penile cancers, Erectile Dysfunction, Peyronie's Disease, Priapism. He has expertise in open, laparoscopic and robot treatment of these genitourinary malignancies.
Dr. Bivalacqua has received national and international recognition for his research involving the pathophysiology and novel treatment strategies for Erectile Dysfunction and Priapism. His laboratory currently investigates novel molecular pathways that are involved in post-radical prostatectomy erectile dysfunction, diabetes-induced erectile dysfunction, and sickle cell disease-associated priapism. He was the first person to describe the use of gene therapy targeting the endothelium of the penis for the treatment of erectile dysfunction. Through his scientific discoveries, new pharmacological and gene therapies have been developed for male erectile dysfunction.
|| Misop Han, M.D.
|Dr. Misop Han is an Associate Professor of Urology at the Brady Urological Institute at The Johns Hopkins Hospital. He received his undergraduate, medical school and urology training at Johns Hopkins. After his training, he worked as an Assistant Professor of Urology at the Feinberg School of Medicine at Northwestern University and as a urologist at Northwestern Memorial Hospital in Chicago, Illinois. Dr. Han was head of Northwestern University's clinical database for prostate cancer research. In 2006, he was recruited back to join the faculty at the Brady Urological Institute at Johns Hopkins Hospital.
Dr. Han is a board-certified urologist whose main clinical focus is in urological oncology with a special emphasis on prostate and kidney cancers. He specializes in nerve-sparing radical retropubic prostatectomy, robotic-assisted laparoscopic radical prostatectomy and laparoscopic nephrectomy.
Dr. Han has received recognition for his research involving the outcome of surgery for prostate cancer and has received national awards for his research. His research interests include the outcome of radical prostatectomy and prediction modeling (what happens to men following surgery for prostate cancer). He has published extensively in these subjects(click here for details). He is actively involved in several clinical research projects with the database of more than 14,000 men who received surgery for prostate cancer at The Johns Hopkins Hospital.
||Brian R. Matlaga, M.D., M.P.H.
Office: 410 502-7710
Appointments: 410 955-6100
Fax: 410 502-7711
Brian Matlaga is Associate Professor of Urology at The Brady Urological
Institute and the Director of Stone Disease at Johns Hopkins Bayview
Medical Center. Dr. Matlaga came to Johns Hopkins after completing
a fellowship in minimally invasive surgery and metabolic stone disease.
During his fellowship he was designated an American Foundation for
Urologic Disease Research Scholar, and was awarded the Outstanding
Research Scholar honor in recognition of his work involving the
treatment of patients with stone disease.
Dr. Matlaga's main clinical
interest is the minimally invasive treatment of patients with metabolic
stone disease, including percutaneous nephrolithotomy, ureteroscopy,
and shock wave lithotripsy. In addition, Dr. Matlaga has an interest
in the holmium laser enucleation of the prostate (HoLEP), a minimally
invasive laser therapy for men with benign prostatic enlargement.
As the Director of Stone Disease,
Dr. Matlaga is actively engaged in clinical and basic science research
addressing the questions of: Which patients develop stones? How
do stones form? How well are we treating patients with stones?
||Alan W. Partin, M.D., Ph.D.
| Alan W.Partin M.D., Ph.D., Professor of Urology the Johns Hopkins Medical Institution, has both basic science and clinical interest in prognosis prediction for men with prostate cancer. Dr. Partin's laboratories and clinical and surgical interest are focused on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians. Dr. Partin's laboratories have investigated many new serum tests, some of which are soon to become available for the diagnosis of prostate cancer as well as basics science investigation of new proteins, which may help in detection, and staging of prostate cancer. In addition, Dr. Partin has an academic and clinical interest in treatment of benign prostatic hyperplasia with an emphasis on minimally invasive techniques for treatment of this common disease of men.
||Christian Pavlovich, M.D
Office: 410 550-0013
Fax: (410) 550-4188
|Dr. Pavlovich came to Johns Hopkins after completing a Urologic Oncology fellowship at the National Cancer Institute. His practice is dedicated primarily to the treatment of prostate, kidney and bladder cancer, as well as to the treatment of benign prostatic diseases. He is experienced in open, laparoscopic, and robotic minimally invasive surgery for the management of urologic tumors, including nerve-sparing laparoscopic and robot- assisted radical prostatectomy, laparoscopic and robotic nephrectomy and partial nephrectomy, and robotic radical cystectomy.
A particular expertise of his is the robotic extraperitoneal (or retroperitoneal) approach to the prostate and kidney for patients with prostate or kidney cancer. This approach, which avoids entry into the abdominal cavity, is ideally suited for patients that have had prior abdominal or inguinal operations (e.g. hernia repairs, appendectomy, colectomy) or who have inflammatory conditions (e.g. Crohn’s disease, ulcerative colitis, diverticulitis) that might make an abdominal robotic approach more hazardous.
Dr. Pavlovich is accepting new patients and is delighted to offer second opinions regarding the treatment of any urologic malignancy.
||Phillip M. Pierorazio, M.D.
Office: 410 502 5984
Appointments: 410 955 6100
Fax: 410 502 7711
|Dr. Phillip Pierorazio, originally from New York, received his undergraduate degree from Georgetown University in Washington, DC and his medical degree from Columbia University, College of Physicians & Surgeons in New York City. Prior to starting residency, he was accepted and spent a year as a Doris Duke Clinical Research Fellow in Urologic Oncology. After completing residency and advanced training at the Johns Hopkins Hospital, he joined the staff of the James Buchanan Brady Urological Institute, Department of Urology and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Assistant Professor of Urology and Oncology.
Dr. Pierorazio has expertise in all malignancies of the urinary tract, including kidney, bladder, prostate, testis, adrenal, penile and urethral cancer. He performs both open and minimally-invasive surgeries including laparoscopic and robotic surgeries of the kidney, bladder and prostate. He has a special interest in kidney cancer, including partial nephrectomy for early stage disease and high-risk surgeries for patients with advanced urological cancers.
||Ashley E. Ross, M.D., Ph.D.
Office: (443) 287-7225
|Ashley E. Ross, MD, PhD, Assistant professor of Urology, Oncology and Pathology, was born in Buffalo New York and graduated from The Johns Hopkins School of Medicine with graduate and medical degrees. He joined the faculty after completing his general surgery and urology training at Johns Hopkins.
Dr. Ross has an active clinical practice which focuses on Prostate Cancer and Prostatic Diseases such as Benign Prostatic Hyperplasia. He has expertise in open and robotic treatment of prostate cancer as well as in focal and salvage prostate cryotherapy and in the active surveillance of prostate cancer. He additionally has expertise in the treatment of benign prostatic hyperplasia through the use of transurethral resection, laser photo-vaporization and through open surgical approaches. As an active member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr. Ross participates in multi-disciplinary approaches to the treatment of prostate cancer.
||Edward M. Schaeffer, M.D., Ph.D.
|Edward M (Ted) Schaeffer, MD, PhD, Assistant Professor of Urology, Oncology and Pathology, was born in Palo Alto California and graduated from University of Chicago with undergraduate, graduate and medical degrees. He joined the faculty after completing his general surgery and urology training at Johns Hopkins.
Dr. Schaeffer has an active clinical practice in Urologic Oncology specializing in Prostate, Bladder and Kidney cancer. He has expertise in open, laparoscopic and robot treatment of these malignancies. As an active member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr Schaeffer participates in multidisciplinary approaches to the treatment of genitourinary cancers.
Dr Schaeffer is also a fully trained scientist and an expert in prostate development and prostate carcinogenesis. His laboratory currently investigates novel pathways of prostate and bladder carcinogenesis through utilization of experimental embryology and systems of epithelial injury repair.
||Stephen M. Schatz, M.D.
Office: (410) 550-3506
|Dr. Stephen M. Schatz is Assistant Professor of Urology at the Johns Hopkins School of Medicine. He comes to Johns Hopkins from private practice in San Francisco.
Dr. Schatz received his B.A. in history from Columbia College and his M.D. from the University of Pittsburgh School of Medicine, where he was elected to the Alpha Omega Alpha medical honor society. He completed his internship in surgery and residency in urology at Mayo Clinic in Rochester, Minnesota.
He practices general urology, with interests in benign prostate enlargement, kidney stone treatment and prevention, and urologic oncology - cancers of the urinary tract, including prostate, kidney, bladder, and testis.
||Edward James Wright, M.D.
Office: (410) 550-3506
|Dr. Wright is Director of Neurourology and Chief of Urology at Johns Hopkins Bayview Medical Center. He completed a fellowship in female urology, reconstructive urology and urodynamics. His clinical and research interests are in male and female urinary incontinence, complex voiding dysfunction and pelvic genitourinary reconstructive surgery.
For Prostate Cancer:
Robotic Radical Prostatectomy a minimally invasive surgical technique to remove the prostate gland
in patients diagnosed with prostate cancer using robotic assisted
Prostatectomy a minimally invasive
surgical technique to remove the prostate gland through an incision
made in the perineum.
For Kidney Stones:
shock wave lithotripsy (ESWL) a non invasive technique that uses sound waves (also called shock
waves) to break a kidney stone into small pieces
Ureteroscopy: is a procedure using a thin telescope
(ureteroscope), which is passed through the urethra (channel through
which urine flows out of the bladder) used to treat stones within
kidney or ureter.
Nephrolithotomy (PCNL): a minimally
invasive technique for removing large kidney stones through a small
incision made in the skin.
For Kidney Donation:
Live Donor Nephrectomy:is
a minimally invasive technique of kidney donation, which provides
the least amount of discomfort for the donor while maintaining the
health and quality of the kidney for transplantation.
For Kidney Blockage or Kidney Cysts:
Pyeloplasty:a minimally invasive
surgical technique used to reconstruct the drainage system of the
kidney in patients suffering from blockage of a kidney at the ureteropelvic
junction (i.e. the connection between the ureter or drainage tube
and the kidney).
Laparoscopic Renal Cyst Ablationa minimally invasive surgical technique to
excise symptomatic kidney cyst.
For Adrenal Tumors:
Adrenalectomya minimally invasive
surgical technique for removing a diseased
or cancerous adrenal gland.
these video clips include footage from an actual surgery which
some viewers may find difficult to watch.
Robotic Radical Prostatectomy
Laparoscopic Live Donor Nephrectomy
Laparoscopic Live Donor Nephrectomy
Percutaneous Nephrolithotomy (PCNL)
Pelvic Organ Prolapse Repair (COLPOSUSPENSION)
Laparoscopic Pelvic Organ Prolapse Repair(COLPOSUSPENSION)